North Dallas Bank & Trust Co. Declares Regular Dividend
DALLAS, March 20, 2024 (GLOBE NEWSWIRE) -- On March 19, 2024, the Board of Directors of North Dallas Bank & Trust Co. (OTCBB: NODB) declared a regular dividend of $0.10 per share, payable to shareholders of record as of April 19, 2024, with said dividend payable on April 26, 2024.
The current dividends are based on NDBT’s current financial condition and are not a guarantee that dividends will continue to be paid in the future. Further information about NDBT’s dividend declaration is available from Glenn Henry, Chief Financial Officer.
ABOUT NDBT
Founded in 1961, NDBT (North Dallas Bank & Trust Co.) is an independent community bank with five banking centers located in Dallas, Addison, Frisco, Las Colinas, and Plano. Headquartered on the corner of Preston Road and LBJ at 12900 Preston Road in Dallas, NDBT is dedicated to helping people make smarter choices in business and life by offering authentic banking solutions, wealth management, and innovative online banking tools. Member FDIC. NDBT is an Equal Housing Lender. For more information, call 972.716.7100, or visit online at www.ndbt.com.
Media Contact:
Brian C. Jensen
972-716-7124
brian.jensen@ndbt.com
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year